Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | NovaBay Pharmaceuticals, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
Mi | NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates | 29 | Business Wire | EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. the "Company") (NYSE American: NBY) announces that a quorum was reached and that all proposals in the Company's Definitive Proxy... ► Artikel lesen | |
20.05. | NovaBay Pharmaceuticals Stock Is Up 50%: What's Going On? | 5 | Benzinga.com | ||
09.05. | NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results | 67 | Business Wire | EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2024 and provides a business update.
"Net... ► Artikel lesen | |
22.04. | NovaBay Pharmaceuticals receives NYSE notice for compliance | 8 | Seeking Alpha | ||
19.04. | NovaBay Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
17.04. | NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report | 5 | Seeking Alpha | ||
29.03. | NovaBay Pharmaceuticals, Inc. - 10-K/A, Annual Report | 4 | SEC Filings | ||
26.03. | NovaBay Pharmaceuticals: Q4 Earnings Insights | 3 | Benzinga.com | ||
26.03. | NovaBay Pharmaceuticals, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
26.03. | NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results | 51 | Business Wire | EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2023 and provides a business update.
"Quarterly... ► Artikel lesen | |
25.03. | NovaBay Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.03. | NovaBay Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
14.03. | NovaBay Pharmaceuticals To Sell DERMAdoctor Skincare Business | 2 | RTTNews | ||
14.03. | NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023 | 135 | Business Wire | EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces that the... ► Artikel lesen | |
13.03. | Eyenovia, Inc.: NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals | 1 | GlobeNewswire (USA) | ||
30.01. | NovaBay Pharmaceuticals posts 64% rise in 2023 Avenova unit subscription-based sales | 8 | Seeking Alpha | ||
10.01. | NovaBay Pharmaceuticals, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
09.01. | Sonoma Pharmaceuticals, Inc.: NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network | 593 | ACCESSWIRE | EMERYVILLE, CA and BOULDER, CO / ACCESSWIRE / January 9, 2024 / NovaBay Pharmaceuticals, Inc. (NYSE American:NBY) and Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) today announced an agreement for the... ► Artikel lesen | |
21.12.23 | NovaBay Pharmaceuticals, Inc. - 8-K, Current Report | 4 | SEC Filings |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NEL | 4.874 |
EVOTEC | 3.524 |
NVIDIA | 3.264 |
VOLKSWAGEN | 2.158 |
TUI | 2.106 |
GAMESTOP | 1.963 |
BAYER | 1.635 |
PLUG POWER | 1.381 |
BYD | 1.378 |
RHEINMETALL | 1.239 |
AIXTRON SE | 1.152 |
SUPER MICRO COMPUTER | 1.017 |
DEUTSCHE LUFTHANSA | 999 |
SIEMENS ENERGY | 835 |
JINKOSOLAR | 820 |
BIONTECH | 819 |
HELLOFRESH | 796 |
SALESFORCE | 756 |
BASF | 698 |
TESLA | 622 |
MERCEDES-BENZ | 618 |
PORSCHE AG | 608 |
THYSSENKRUPP | 606 |
RWE | 603 |
UIPATH | 584 |